Position in BMY
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$567,902
-$36,535 QoQ
Shares Held
9,856
-1.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#1,460
of 2,514 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Waterloo Capital, L.P. holds $23,385,515 across 8 Drug Manufacturers - General names. BMY ranks #6 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
24,785 | $6,294,646 | |
| 2 | ABBV |
AbbVie Inc.
|
23,335 | $5,872,019 | |
| 3 | LLY |
ELI LILLY & Co
|
4,584 | $5,498,187 | |
| 4 | MRK |
Merck & Co., Inc.
|
27,308 | $3,509,078 | |
| 5 | PFE |
Pfizer Inc
|
28,858 | $694,900 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
9,856 | $567,902 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
3,755 | $474,406 | |
| 8 | AMGN |
Amgen Inc
|
1,310 | $474,377 |
All Filings in BMY
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $567,902 | 9,856 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $604,437 | 9,966 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $354,170 | 6,566 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $410,680 | 9,106 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $912,005 | 19,702 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,046,267 | 49,947 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,729,095 | 30,571 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $204,838 | 3,959 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||